for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Newron Receives FDA Rare Pediatric Disease Designation For Sarizotan

Nov 19 (Reuters) - Newron Pharmaceuticals SpA:

* NEWRON RECEIVES FDA RARE PEDIATRIC DISEASE DESIGNATION FOR SARIZOTAN FOR THE TREATMENT OF RETT SYNDROME Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up